Silverarc Capital Management’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.29M | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $903K | Buy |
|
|||||
|
2024
Q3 | $799K | Hold |
|
|||||
|
2024
Q2 | $870K | Sell |
|
|||||
|
2024
Q1 | $5.13M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $857K | Sell |
|
|||||
|
2022
Q2 | $1.55M | Buy |
|
|||||
|
2022
Q1 | $2.26K | Buy |
|
|||||
|
2021
Q4 | $2.23M | Buy |
|
|||||
|
2021
Q3 | $1.35M | Sell |
|
|||||
|
2021
Q2 | $2.18K | Sell |
|
|||||
|
2021
Q1 | $3.05M | Buy |
|